Evidence map›Paper›PMID 34542583›Full record

ArticleAmerican journal of clinical pathology2022

Evaluation of Cytologic Sample Preparations for Compatibility With Nucleic Acid Analysis.

Laure Sorber, Bart Claes, Karen Zwaenepoel, Bieke Van Dorst, Koen De Winne, Els Fransen, Reinier Wener, Therese Lapperre, Filip Lardon, Patrick Pauwels

Abstract read
In one paragraph

Article in American journal of clinical pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Laure SorberCenter for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.ORCID 0000-0002-7172-700X
Bart ClaesBiocartis NV, Mechelen, Belgium.
Karen ZwaenepoelCenter for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.
Bieke Van DorstBiocartis NV, Mechelen, Belgium.
Koen De WinnemiDIAGNOSTICS, Heverlee,Belgium.
Els FransenBiocartis NV, Mechelen, Belgium.
Reinier WenerDepartment of Pulmonology, University Hospital Antwerp (UZA), Edegem, Belgium.
Therese LapperreDepartment of Pulmonology, University Hospital Antwerp (UZA), Edegem, Belgium.
Filip LardonCenter for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.
Patrick PauwelsCenter for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.

Funding

Vlaanderen-Agentschap Innoveren & Ondernemen HBC.2020.2173
6 · The paper itself

Abstract

objectivesIn this study, the influence of several key elements of the cytologic sample workflow on DNA and RNA content was evaluated.

methodsThe A549 cell line, patient-derived organoids, and pleural effusions were used to investigate the effect of (1) several collection media and delayed time to processing; (2) cytology specimens; (3) cytologic staining; and (4) formalin-fixed, paraffin-embedded (FFPE) cell block processing on nucleic acid quality and quantity as determined by fragment analyzer, Qubit analysis (Thermo Fisher Scientific), and quantitative polymerase chain reaction-based analysis on the Idylla platform (Biocartis).

resultsAlcohol-based collection media (CytoRich Red [Thermo Fisher Scientific] and EtOH95%) displayed high DNA and RNA preservation capacity, while phosphate-buffered saline and, to a lesser extent, formalin were associated with high RNA quality. Cytospin and smear cytology specimens were subject to DNA and RNA loss. Cytologic staining had no further impact on sample quality, hence destaining is not necessary. Both H&E-stained and unstained FFPE sections are compatible with nucleic acid analysis, despite a strong decrease in DNA and RNA quality.

conclusionsAlthough several key elements of the cytologic sample workflow have an influence on DNA and RNA quality and quantity, the selection of these elements is also dependent on the downstream (ancillary) testing methods.

Indexed as

FormaldehydeNucleic AcidsHumansParaffin EmbeddingRNASpecimen HandlingTissue FixationFormaldehydeNucleic AcidsRNA

Identifiers

PMID34542583
PMCPMC8824667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.